Form4insider filings, from the source

SEC Form 4/A · accession 0001140361-15-015691

CESCA THERAPEUTICS INC. · KOOL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Matthew T Plavan
Officer — CEO & Director · Director
Period of report
Jun 1, 2012
Accepted (ET)
Apr 17, 2015 · 2:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000811212

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2,F3Jun 1, 2012F3,300$0.87D115,450D
Common StockF1,F2,F4Jul 29, 2012F8,263$0.88D107,187D
Common StockF1,F2,F5Jun 1, 2013F3,300$1.17D103,887D
Common StockF1,F2,F6Jul 29, 2013F8,402$1.16D95,485D
Common StockF1,F2,F7Jun 1, 2014F3,395$1.71D302,090D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses